These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 3074518)

  • 1. Ceftazidime in febrile SLE patients.
    Boey ML; Feng PH
    Singapore Med J; 1988 Aug; 29(4):393-5. PubMed ID: 3074518
    [No Abstract]   [Full Text] [Related]  

  • 2. [Ceftazidime in the treatment of infections in intensive care. Experience with 20 clinical cases].
    Liverta E; Pasquetti G; Carnevali M; Bellucci MC
    Minerva Anestesiol; 1986; 52(1-2):47-9. PubMed ID: 3526183
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical study of 42 patients treated with ceftazidime].
    Farci G; Laconi R; Lai ME; Balestrieri A
    Clin Ter; 1985 Nov; 115(3):169-72. PubMed ID: 3910330
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of ceftazidime in febrile incidents in immunocompromised haematological patients.
    d'Oliveira JJ; Pereira ME; Mateus LM; Monteiro JM; Parreira AS; Soares AD
    J Int Med Res; 1986; 14(1):30-4. PubMed ID: 3514313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment with ceftazidime of difficult and severe (hospital and non-hospital) infections].
    Sueri L; Scalzini A; Barni C; Chiodera A
    G Ital Chemioter; 1985; 32(2):399-402. PubMed ID: 3914431
    [No Abstract]   [Full Text] [Related]  

  • 6. Spectrum and outcomes of infections in systemic lupus erythematosus pateients.
    Jamil B; Rafi S; Hussain H; Hameed K
    J Coll Physicians Surg Pak; 2006 Sep; 16(9):625-6. PubMed ID: 16945243
    [No Abstract]   [Full Text] [Related]  

  • 7. [Infection and systemic lupus erythematosus: analysis of a series of 145 patients].
    Formiga Pérez F; Moga Sampere I; Canet González R; Pac Ferraz M; Mitjavila Villero F; Fernández Nogués F
    Rev Clin Esp; 1993 Jul; 193(3):105-9. PubMed ID: 8356286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ceftazidime in the treatment of acute severe infections in children and adults.
    Păun L; Ceauşu E
    Arch Roum Pathol Exp Microbiol; 1989; 48(2):177-84. PubMed ID: 2699410
    [No Abstract]   [Full Text] [Related]  

  • 9. Local and general treatment with ceftazidime as monotherapy in central nervous system infections and in septicemic infection.
    Fiori GP; Dietz A; Montanari M; Torre D
    Int J Clin Pharmacol Ther Toxicol; 1985 Jun; 23(6):326-8. PubMed ID: 3894254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of ceftazidime in the treatment of osteomyelitis and osteoarthritis.
    De Bastiani G; Nogarin L; Molinaroli F; Bragantini A; Fostini R
    Int J Clin Pharmacol Ther Toxicol; 1986 Dec; 24(12):677-9. PubMed ID: 3546169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of a new beta-lactam antibiotic, ceftazidime, in the neurosurgical intensive care unit. Preliminary observations].
    Ravelli V; Buonaguidi R; Lutzemberger L
    Minerva Anestesiol; 1985 Sep; 51(9):471-3. PubMed ID: 3913880
    [No Abstract]   [Full Text] [Related]  

  • 12. Infections in systemic lupus erythematosus.
    Oh HM; Chng HH; Boey ML; Feng PH
    Singapore Med J; 1993 Oct; 34(5):406-8. PubMed ID: 8153686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrent systemic lupus erythematosus and salmonellosis.
    Lovy MR; Ryan PF; Hughes GR
    J Rheumatol; 1981; 8(4):605-12. PubMed ID: 7299762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ceftazidime in the treatment of bacterial meningitis].
    Duniewicz M; Stanková M; Absolonová V; Havlík J; Potuzník V; Lochmann O
    Sb Lek; 1988 Oct; 90(10):318-22. PubMed ID: 3060978
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of ceftazidime in the treatment of otorhinolaryngoiatric bacterial infections.
    Vellucci A; Marcucci L; Greco D; Schinaia N; Caterini A; Benedetti M
    Int J Clin Pharmacol Ther Toxicol; 1987 May; 25(5):282-8. PubMed ID: 3298082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ceftazidime (Fortaz).
    Med Lett Drugs Ther; 1985 Oct; 27(698):85-7. PubMed ID: 3900663
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections.
    McKinnon PS; Paladino JA; Schentag JJ
    Int J Antimicrob Agents; 2008 Apr; 31(4):345-51. PubMed ID: 18313273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mannose-binding lectin and susceptibility to infection in Chinese patients with systemic lupus erythematosus.
    Mok MY; Ip WK; Lau CS; Lo Y; Wong WH; Lau YL
    J Rheumatol; 2007 Jun; 34(6):1270-6. PubMed ID: 17552055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical use of ceftazidime in gram negative pulmonary pathologies.
    Barberis S; Cristaldi G; Galietti F; Giorgis GE; Massaglia GM
    Panminerva Med; 1985; 27(4):189-94. PubMed ID: 3913889
    [No Abstract]   [Full Text] [Related]  

  • 20. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
    Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
    Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.